We assessed the associations of polymorphisms and haplotypes in XRCC1 with skin cancer risk in a nested case–control study within the Nurses' Health Study (219 melanoma, 286 squamous cell carcinoma (SCC) and 300 basal cell carcinoma (BCC), and 873 controls). Here, XRCC1 is linked to skin neoplasm.